Enhance MD vs bmiMD: Semaglutide $49 vs bmiMD Tirzepatide Plans
Enhance MD vs bmiMD is a cost and plan tradeoff: Enhance MD touts semaglutide from $49 and tirzepatide from $99 for the first month with flat-rate pricing at every dose; bmiMD focuses on compounded tirzepatide with month-to-month pricing from $179 and lower per-month rates for 3, 6, and 12 month plans. Early verdict: choose Enhance MD for the lowest first-month entry and dual-compound availability; choose bmiMD for lower long-term monthly equivalents and subscription shipping.
Try Enhance MD: See $49 semaglutide offer
Comparison snapshot: pricing, compounds, and commitments
Both platforms offer clinician-reviewed telehealth care and compounded GLP-1 options. Key differences center on initial price points, compound selection, billing commitment, and shipping or subscription features. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality for both providers.
Most distinctive differences to weigh
- First-month entry price: Enhance MD lists semaglutide from $49 and tirzepatide from $99 for the first month. bmiMD lists tirzepatide at $179 for one month.
- Compound selection: Enhance MD offers both compounded semaglutide and tirzepatide on one platform. bmiMD presentation centers on compounded tirzepatide.
- Long-term billing and commitments: bmiMD provides lower monthly equivalents with multi-month plans—$159 three-month, $149 six-month, and $139 12-month—while Enhance MD emphasizes flat-rate pricing that stays the same at every dose after introductory pricing; specific ongoing rates are not always prominently published before intake.
- Shipping and subscription benefits: bmiMD includes free subscription shipping and online refills; Enhance MD materials mention lab testing cadence and clinician-directed care but do not advertise free shipping in the captured evidence.
Direct comparison table
| Criteria | Enhance MD | bmiMD |
|---|---|---|
| Starting price | Semaglutide from $49 first month; tirzepatide from $99 first month | Tirzepatide $179 month-to-month |
| Multi-compound availability | Semaglutide and tirzepatide available on one platform | Compounded tirzepatide focused |
| Long-term pricing | Flat-rate pricing stated: same price at every dose; ongoing flat rate may be higher than intro | Lower long-term monthly equivalent with commitments: $159 3-mo, $149 6-mo, $139 12-mo |
| Shipping and refills | Not advertised as free in captured evidence | Free subscription shipping and online refills |
| Clinical and regulatory notes | Clinician-directed; compounded medications not FDA-approved | Clinician-reviewed; compounded medications not FDA-approved |
Pricing details and what they mean
Enhance MD positions itself as one of the lowest first-month cost options for both semaglutide and tirzepatide, which may matter if initial entry cost is the priority. Their messaging emphasizes a flat-rate model where price does not escalate with higher doses during titration, though the captured evidence notes that ongoing flat-rate pricing can be higher than the introductory rate and may not be prominently published before intake.
Commitments, shipping, and program design
bmiMD structures tirzepatide around subscription lengths. The captured pricing shows lower monthly equivalents with longer commitments and free subscription shipping. bmiMD also advertises 24/7 clinician access and online refills. Enhance MD highlights clinician-directed care, metabolic lab testing every six months in some captured lines, and a high patient volume claim (10,000+ patients treated).
Safety and medication form
Both providers offer compounded medications and include the same regulatory qualifier: compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Treatment at both sites is available only when a licensed clinician determines it is medically appropriate; bmiMD states a refund if not eligible for the program in captured evidence.
Explore bmiMD tirzepatide plans
How to choose: Enhance MD vs bmiMD
Enhance MD vs bmiMD comes down to entry price versus long-term plan structure. Enhance MD is notable for the lowest first-month prices for semaglutide ($49) and tirzepatide ($99) and for offering both compounds on one platform with flat-rate dosing. bmiMD is focused on compounded tirzepatide with multi-month subscriptions that reduce the monthly equivalent and include free subscription shipping and online refills.
Compare Enhance MD dosing and pricing
Final thoughts and quick recommendations
Primary keyword recap: Enhance MD vs bmiMD highlights a low first-month entry and dual-compound availability at Enhance MD versus lower long-term monthly equivalents, free subscription shipping, and subscription commitments at bmiMD. Both use compounded medications and require clinician review.
See bmiMD subscription options
Start with Enhance MD pricing details
Choose Enhance MD if…
You prioritize the lowest first-month pricing for semaglutide (from $49) or tirzepatide (from $99) and want access to both compounded semaglutide and tirzepatide on one platform with flat-rate dosing during titration.
Choose bmiMD if…
You prefer a subscription model with free shipping and lower long-term monthly equivalents for tirzepatide by committing to 3, 6, or 12 month plans and value online refills and continuous clinician access.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →More comparisons
